FXH vs. SBIO
FXH (First Trust Health Care AlphaDEX Fund) and SBIO (ALPS Medical Breakthroughs ETF) are both Health & Biotech Equities funds - FXH tracks the StrataQuant Health Care Index while SBIO tracks the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, FXH returned 7.03%/yr vs 8.02%/yr for SBIO. A 0.69 correlation means they provide meaningful diversification when combined. FXH charges 0.61%/yr vs 0.50%/yr for SBIO.
Performance
FXH vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FXH achieves a 0.68% return, which is significantly higher than SBIO's -0.39% return. Over the past 10 years, FXH has underperformed SBIO with an annualized return of 7.03%, while SBIO has yielded a comparatively higher 8.02% annualized return.
FXH
- 1D
- 1.48%
- 1M
- 1.65%
- YTD
- 0.68%
- 6M
- -0.88%
- 1Y
- 13.28%
- 3Y*
- 3.52%
- 5Y*
- 0.56%
- 10Y*
- 7.03%
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
FXH vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FXH First Trust Health Care AlphaDEX Fund | 0.68% | 10.16% | 0.96% | -4.53% | -12.24% | 15.20% | 28.00% | 22.26% | -1.33% | 21.82% |
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between FXH and SBIO is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.58 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.69 |
The correlation between FXH and SBIO shifts across timeframes, from 0.52 (1 year) to 0.69 (all time), reflecting how their relationship changes across market environments.
FXH vs. SBIO - Sectors Allocation Comparison
Sectors
FXH
SBIO
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FXH
SBIO
Basic Materials
FXH
-
SBIO
-
Communication Services
FXH
-
SBIO
-
Consumer Cyclical
FXH
-
SBIO
-
Consumer Defensive
FXH
-
SBIO
-
Energy
FXH
-
SBIO
-
Financial Services
FXH
-
SBIO
Industrials
FXH
-
SBIO
-
Real Estate
FXH
-
SBIO
-
Technology
FXH
-
SBIO
-
Utilities
FXH
-
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FXH vs. SBIO — Risk / Return Rank
FXH
SBIO
FXH vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Health Care AlphaDEX Fund (FXH) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FXH | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.39 | ||
| Sortino ratioReturn per unit of downside risk | -1.76 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.36 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.09 | 5.19 | -4.10 |
| Martin ratioReturn relative to average drawdown | 3.33 | 15.57 | -12.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FXH | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.85 | 2.24 | -1.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.08 | -0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | 0.24 | +0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.21 | +0.30 |
Drawdowns
FXH vs. SBIO - Drawdown Comparison
The maximum FXH drawdown since its inception was -43.70%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for FXH and SBIO.
Loading charts...
Drawdown Indicators
| FXH | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.70% | -63.06% | +19.36% |
Max Drawdown (1Y)Largest decline over 1 year | -12.20% | -12.66% | +0.46% |
Max Drawdown (3Y)Largest decline over 3 years | -17.53% | -42.44% | +24.91% |
Max Drawdown (5Y)Largest decline over 5 years | -29.49% | -53.10% | +23.61% |
Max Drawdown (10Y)Largest decline over 10 years | -30.61% | -63.06% | +32.45% |
Current DrawdownCurrent decline from peak | -9.07% | -16.79% | +7.72% |
Average DrawdownAverage peak-to-trough decline | -9.46% | -28.45% | +18.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.99% | 4.22% | -0.23% |
Volatility
FXH vs. SBIO - Volatility Comparison
The current volatility for First Trust Health Care AlphaDEX Fund (FXH) is 4.16%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that FXH experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FXH | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.16% | 9.48% | -5.32% |
Volatility (6M)Calculated over the trailing 6-month period | 11.17% | 22.70% | -11.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.75% | 29.42% | -13.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.52% | 33.56% | -17.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.47% | 33.17% | -14.70% |
FXH vs. SBIO - Expense Ratio Comparison
FXH has a 0.61% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Dividends
FXH vs. SBIO - Dividend Comparison
FXH's dividend yield for the trailing twelve months is around 0.85%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
FXH First Trust Health Care AlphaDEX Fund | 0.85% | 0.75% | 0.41% | 0.24% | 0.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
FXH and SBIO have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to FXH (4.16%). In terms of maximum drawdown, FXH dropped -43.70% vs SBIO's -63.06%.
On 10-year performance, SBIO leads with 8.02% vs 7.03% for FXH. On fees, SBIO is cheaper at 0.50% per year. On volatility, FXH has been the lower-risk option at 4.16%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 8.02% return vs 7.03%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.61% for FXH.
FXH has the higher dividend yield at 0.85%, compared with 0.00% for SBIO.
FXH tracks StrataQuant Health Care Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: First Trust and SS&C. Their fees differ too: 0.61% for FXH and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (2.24 vs 0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FXH and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer